Gilead Sciences
GILD
1,563 hedge funds and large institutions have $56.7B invested in Gilead Sciences in 2020 Q4 according to their latest regulatory filings, with 211 funds opening new positions, 520 increasing their positions, 686 reducing their positions, and 164 closing their positions.
29% more first-time investments, than exits
New positions opened: 211 | Existing positions closed: 164
2% more funds holding
Funds holding: 1,537 → 1,563 (+26)
0.4% less ownership
Funds ownership: 78.03% → 77.63% (-0.4%)
8% less capital invested
Capital invested by funds: $61.8B → $56.7B (-$5.12B)
16% less call options, than puts
Call options by funds: $1.44B | Put options by funds: $1.72B
22% less funds holding in top 10
Funds holding in top 10: 27 → 21 (-6)
24% less repeat investments, than reductions
Existing positions increased: 520 | Existing positions reduced: 686
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$275M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$272M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$155M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$112M |
| 5 |
Millennium Management
New York
|
+$110M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$398M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$239M |
| 3 |
Bank of New York Mellon
New York
|
-$158M |
| 4 |
AIG
American International Group
New York
|
-$131M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$122M |
GILD Hedge Fund Activity: Q4 2020 in Review
1,563 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2020, worth a combined $56.7B — down 8.3% from $61.8B a quarter earlier.
Buyers outnumbered sellers: 211 funds opened new GILD positions and 164 closed out — a net gain of 47 holders — while 520 added to existing stakes and 686 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $275M. The largest seller was BlackRock, cutting an estimated $398M.
- 1,563 institutional investors held Gilead Sciences (GILD) as of Q4 2020, up from 1,537 in Q3 2020.
- Funds reported $56.7B of Gilead Sciences stock for Q4 2020, down 8.3% quarter-over-quarter.
- 211 funds opened new Gilead Sciences positions in Q4 2020 and 164 closed out, a net change of +47 holders.
- The largest Gilead Sciences buyer in Q4 2020 was Capital Research Global Investors, an estimated $275M added.
- The largest Gilead Sciences seller in Q4 2020 was BlackRock, an estimated $398M sold.
Based on aggregated 13F filings for Q4 2020.